Zhitong Finance App News, Zhejiang Yatai Pharmaceutical (002370.SZ) announced that the company recently received the approval and issuance from the National Medical Products Administration regarding the "Drug Supplementary Application Approval Notice" for Injection Pantoprazole Sodium, which has passed the evaluation of generic drug quality and efficacy consistency. Injection Pantoprazole Sodium is suitable for acute upper gastrointestinal bleeding caused by duodenal ulcers, gastric ulcers, moderate to severe reflux esophagitis, acute gastric mucosal lesions, and complex gastric ulcers.